dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp07031

General Description

Peptide name : [G10a]2-SHa

Source/Organism : Analog of temporin SHa

Linear/Cyclic : Linear

Chirality : Mix

Sequence Information

Sequence : FLSGIVGMLaKLFKFLKaLMFLSGIVG

Peptide length: 27

C-terminal modification: Linear

N-terminal modification : Amidation

Non-natural peptide information:

Activity Information

Assay type : Resazurin dye assay

Assay time : 48-h

Activity : IC50 = 14.31 ± 1.37 µM

Cell line : HepG-2

Cancer type : Liver Cancer

Other activity : Antimicrobial and Anticancer

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 2901.6578 Dalton

Aliphatic index : 1.370

Instability index : -21.092

Hydrophobicity (GRAVY) : 1.6259

Isoelectric point : 10.302

Charge (pH 7) : 2.7571

Aromaticity : 14.81

Molar extinction coefficient (cysteine, cystine): (0, 0)

Hydrophobic/hydrophilic ratio : 4

hydrophobic moment : 0.8081

Missing amino acid : A,C,D,E,H,N,P,Q,R,T,W,Y

Most occurring amino acid : L

Most occurring amino acid frequency : 6

Least occurring amino acid : S

Least occurring amino acid frequency : 2

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (48., 22., 51.)

SMILES Notation: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C

Secondary Structure :

Method Prediction
GOR EETTHHHHHHHHHHHHHHHHHEEEEEC
Chou-Fasman (CF) EEEEEEHHHHHHHHHHHHHHEEEECCC
Neural Network (NN) CCCHHHHHHHHHHHHHHHHHHHHCCCC
Joint/Consensus EECCHHHHHHHHHHHHHHHHHEEECCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 35740895.0

Uniprot : Not available

PDB : Not available

CancerPPD : Not available

ApIAPDB : Not available

CancerPPD2 ID: 7071

Reference

1 : Khan AI, et al. Design, Synthesis and Characterization of [G10a]-Temporin SHa Dendrimers as Dual Inhibitors of Cancer and Pathogenic Microbes. Biomolecules. 2022; 12:(unknown pages). doi: 10.3390/biom12060770

Literature

Paper title : Design, Synthesis and Characterization of [G10a]-Temporin SHa Dendrimers as Dual Inhibitors of Cancer and Pathogenic Microbes.

Doi : https://doi.org/10.3390/biom12060770

Abstract : As the technologies for peptide synthesis and development continue to mature, antimicrobial peptides (AMPs) are being widely studied as significant contributors in medicinal chemistry research. Furthermore, the advancement in the synthesis of dendrimers' design makes dendrimers wonderful nanostructures with distinguishing properties. This study foregrounds a temporin SHa analog, [G10a]-SHa, and its dendrimers as globular macromolecules possessing anticancer and antibacterial activities. These architectures of temporin SHa, named as [G10a]-SHa, its dendrimeric analogs [G10a]<sub>2</sub>-SHa and [G10a]<sub>3</sub>-SHa, and [G10a]<sub>2</sub>-SHa conjugated with a polymer molecule, i.e., Jeff-[G10a]<sub>2</sub>-SHa, were synthesized, purified on RP-HPLC and UPLC and fully characterized by mass, NMR spectroscopic techniques, circular dichroism, ultraviolet, infrared, dynamic light scattering, and atomic force microscopic studies. In pH- and temperature-dependent studies, all of the peptide dendrimers were found to be stable in the temperature range up to 40-60 °C and pH values in the range of 6-12. Biological-activity studies showed these peptide dendrimers possessed improved antibacterial activity against different strains of both Gram-positive and Gram-negative strains. Together, these dendrimers also possessed potent selective antiproliferative activity against human cancer cells originating from different organs (breast, lung, prostate, pancreas, and liver). The high hemolytic activity of [G10a]<sub>2</sub>-SHa and [G10a]<sub>3</sub>-SHa dendrimers, however, limits their use for topical treatment, such as in the case of skin infection. On the contrary, the antibacterial and anticancer activities of Jeff-[G10a]<sub>2</sub>-SHa, associated with its low hemolytic action, make it potentially suitable for systemic treatment.